0 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Utility of Fluorescence In Situ Hybridization as a Fetal Surgery Eligibility Criterion for....

Video Published 2026-06-24

Timestops (2)

0:00
What if invasive genetic testing before fetal surgery might …
What if invasive genetic testing before fetal surgery might not actually change your decision? I'm Lizzie Lee from Cinci…
0:23
Researchers reviewed nearly 1000 pregnancies evaluated for f…
Researchers reviewed nearly 1000 pregnancies evaluated for fetal surgery, and found that when imaging. And cell-free DNA…

Topic Overview

A single-speaker discussion examining the clinical utility of fluorescence in situ hybridization (FISH) testing as a prerequisite for fetal surgery eligibility. The speaker presents findings from a study of nearly 1000 pregnancies showing that when ultrasound and cell-free DNA screening indicate low aneuploidy risk, FISH testing provided no additional discriminatory information for surgical candidacy. The core clinical point is that invasive genetic testing may be safely omitted in carefully selected low-risk cases, potentially reducing procedural risk without compromising candidate selection.

Key Takeaways

  • FISH testing matched low-risk ultrasound + cfDNA results 100% of the time in ~1000 pregnancies evaluated for fetal surgery. (0:23)
  • When imaging and cfDNA show low aneuploidy risk, FISH provides no additional discriminatory value for surgical candidacy. (0:23)
  • Invasive FISH may be safely omitted in carefully selected low-risk cases, reducing procedural risk without compromising selection. (0:36)

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Lizzie Lee — host

Chapters

  • 0:00FISH Testing Utility in Fetal Surgery Screening — Single-segment discussion presenting study findings on the redundancy of FISH testing when non-invasive screening already indicates low aneuploidy risk in fetal surgery candidates.

Key claims

  • 0:09Many centers require genetic testing to rule out chromosome abnormalities before fetal surgery, even when ultrasounds and blood tests already look reassuring — Lizzie Lee
  • 0:23A study reviewed nearly 1000 pregnancies evaluated for fetal surgery — Lizzie Lee
  • 0:23When imaging and cell-free DNA screening showed low risk for aneuploidy, the FISH test matched those results 100% of the time — Lizzie Lee
  • 0:36For low-risk pregnancies, FISH did not provide any new information that changed surgery candidacy — Lizzie Lee
  • 0:42In carefully selected low-risk cases, non-invasive screening may be enough, potentially avoiding the FISH procedure — Lizzie Lee
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.
Written for:

FISH Testing Before Fetal Surgery May Be Unnecessary in Low-Risk Pregnancies

The essential version of this episode — what it covers, the points that matter most, and what it changes for you. Written by Kai from the episode transcript and reviewed before publishing.

For the care team · Core brief · AI-written, human-reviewed

The Question

Most fetal surgery programs require invasive genetic testing—typically fluorescence in situ hybridization (FISH)—to exclude aneuploidy before proceeding, even when ultrasound anatomy and cell-free DNA screening are reassuring 0:09. A study from Cincinnati Children's examined whether this invasive step adds discriminatory value in low-risk cases 0:23.

The Finding

In nearly 1000 pregnancies evaluated for fetal intervention, when both imaging and cell-free DNA screening indicated low aneuploidy risk, FISH results were concordant 100% of the time 0:23. The invasive test did not identify any chromosomal abnormalities that would have changed surgical candidacy in this selected population 0:36.

The Implication

For pregnancies already stratified as low-risk by non-invasive methods, FISH may represent procedural risk without informational gain. The discussant suggests that in carefully selected cases, non-invasive screening may suffice, potentially avoiding amniocentesis or chorionic villus sampling 0:42.

What This Means for You

If you refer patients for fetal surgery evaluation, understand that the genetic testing requirement varies by center and may be evolving. When cell-free DNA and detailed anatomic ultrasound are both reassuring, some programs may begin to waive invasive karyotyping. If you counsel families considering fetal intervention, the procedural risks of amniocentesis—membrane rupture, infection, pregnancy loss—may be avoidable in low-risk cases, though this represents a shift from current standard practice at most centers.

This does not apply to pregnancies with structural anomalies suggesting syndromic diagnoses, abnormal cell-free DNA results, or other features raising aneuploidy concern. The 100% concordance held only in a pre-selected low-risk cohort 0:23.

Takeaways from this story

  • In nearly 1000 fetal surgery evaluations, FISH matched non-invasive screening 100% of the time in low-risk pregnancies.
  • Invasive genetic testing added no new information that changed surgical candidacy in this selected population.
  • Some centers may begin waiving FISH when ultrasound and cell-free DNA are both reassuring, reducing procedural risk.

Keywords

chromosome abnormalities aneuploidy fetal surgery fluorescence in situ hybridization FISH cell-free DNA screening ultrasound Cincinnati Children's

Transcript

Comments

Loading comments…